The Kinetic Office: How the Modern Workplace is Engineering Movement into the Daily Grind on August 11, 2026 Posted by
Unlocking the Tumor Microenvironment: UIC Researchers Target Cancer’s "Energy Factories" with Novel Bacterial Protein on August 11, 2026 Posted by
Vaderis Therapeutics Secures $152 Million to Propel Breakthrough HHT Treatment into Phase 3 Trials on August 11, 2026 Posted by
The Invisible Barrier: Why Starting New Medications Is a Crisis for the Chronically Ill on August 11, 2026 Posted by
Beyond the Scale: How Time-Restricted Eating May Sharpen the Aging Brain on August 11, 2026 Posted by
Navigating the Invisible Minefield: A Comprehensive Guide to Identifying and Managing Bipolar Triggers on August 11, 2026 Posted by
The Kinetic Office: How the Modern Workplace is Engineering Movement into the Daily Grind on August 11, 2026 Posted by
Unlocking the Tumor Microenvironment: UIC Researchers Target Cancer’s "Energy Factories" with Novel Bacterial Protein on August 11, 2026 Posted by
Vaderis Therapeutics Secures $152 Million to Propel Breakthrough HHT Treatment into Phase 3 Trials on August 11, 2026 Posted by
The Invisible Barrier: Why Starting New Medications Is a Crisis for the Chronically Ill on August 11, 2026 Posted by
Posted in Medical Innovations Eli Lilly Doubles Down on Genetic Medicine: A $1.9 Billion Bet on Ascidian’s RNA Exon Editing on June 3, 2026 rifanmuazin
Posted in Digital Health Tools The 340B Stand-Off: Eli Lilly Escalates Data Dispute with Hospitals on June 3, 2026 rifanmuazin
Posted in Medical Innovations The High-Stakes Showdown: Eli Lilly Escalates Battle Over 340B Drug Discount Program on June 2, 2026 rifanmuazin
Posted in Digital Health Tools Escalating Standoff: Eli Lilly Issues Ultimatum to Hospitals Over 340B Drug Pricing on June 2, 2026 rifanmuazin
Posted in Medical Innovations The Great Weight-Loss War: CVS Shifts Strategy to Level the Playing Field for Lilly and Novo Nordisk on May 31, 2026 rifanmuazin
Posted in Digital Health Tools The Triple-Agonist Frontier: Eli Lilly’s Retatrutide Sets a New Benchmark in Obesity Treatment on May 22, 2026 rifanmuazin
Posted in Medical Innovations Eli Lilly’s ‘Triple-G’ Retatrutide Sets New Efficacy Benchmark in Landmark Obesity Trial on May 22, 2026 rifanmuazin
Posted in Digital Health Tools Eli Lilly Strengthens Genetic Medicine Portfolio with Acquisition of Engage Bio on May 21, 2026 rifanmuazin
Posted in Medical Innovations The Next Frontier of Weight Loss: Eli Lilly’s Retatrutide Approaches Surgical Efficacy, But Safety Hurdles Loom on May 21, 2026 rifanmuazin
Posted in Medical Innovations Eli Lilly’s Unprecedented Dual Victory: A New Era of Pharmaceutical Dominance on May 19, 2026 rifanmuazin
